Clinical Trial Detail

NCT ID NCT03139331
Title PAZIT Study for Children and Young Adults With Relapsed or Refractory Sarcoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors University of California, San Francisco
Indications

Ewing sarcoma

osteosarcoma

rhabdomyosarcoma

sarcoma

Therapies

Pazopanib + Irinotecan + Temozolomide

Age Groups: child adult

No variant requirements are available.